Hi Ray:
To people who didn't go through all this would think of it as, "over-the-top" drama. My purpose on this post is to remind you to make sure the gadolinium is used in your MRI so, you won't have to go through that part again. (metal injection done near the end of the scans, with my experience)
________________________________________________________________________________________________________
Gadolinium (play /ˌɡædɵˈlɪniəm/ GAD-o-LIN-ee-əm) is a chemical element with the symbol Gd and atomic number 64. It is a silvery-white, malleable and ductile rare-earth metal. It is found in nature only in combined (salt) form. Gadolinium was first detected spectroscopically in 1880 by de Marignac who separated its oxide and is credited with its discovery. It is named for gadolinite, one of the minerals in which it was found, in turn named for chemist Johan Gadolin. The metal was isolated by Lecoq de Boisbaudran in 1886.
Gadolinium metal possesses unusual metallurgic properties, with as little as 1% of gadolinium improving the workability and resistance of iron, chromium, and related alloys to high temperatures and oxidation. Gadolinium as a metal or salt has exceptionally high absorption of neutrons and therefore is used for shielding in neutron radiography and in nuclear reactors. Like most rare earths, gadolinium forms trivalent ions which have fluorescent properties. Gd (III) salts have therefore been used as green phosphors in various applications.
The Gd(III) ion occurring in water-soluble salts is quite toxic to mammals. However, chelated Gd(III) compounds are far less toxic because they carry Gd(III) through the kidneys and out of the body before the free ion can be released into tissue. Because of its paramagnetic properties, solutions of chelated organic gadolinium complexes are used as intravenously administered gadolinium-based MRI contrast agents in medical magnetic resonance imaging. However, in a small minority of patients with renal failure, at least four such agents have been associated with development of the rare nodular inflammatory disease nephrogenic systemic fibrosis. This is thought to be due to gadolinium ion itself, since Gd(III) carrier molecules associated with the disease differ.
Pal
